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Highlights (85 words):  
 The burden of “nutritional” rickets due to solar vitamin D and dietary calcium 
deficiency is increasing worldwide. Nutritional osteomalacia co-exists with rickets 
in children, but also affects adults and adolescents with closed epiphyses who 
mostly remain undiagnosed.  
 Nutritional osteomalacia is a growing global public health concern and yet the 
true disease burden remains unexplored and neglected. 
 There is a pressing need for non-invasive, clinical diagnostic criteria and studies 
exploring osteomalacia’s true prevalence in vivo and post mortem in order to 
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inform public health policies relating to vitamin D/ calcium supplementation and 
food fortification. 
ABSTRACT 
Osteomalacia and rickets result from defective mineralization when the body is 
deprived of calcium. Globally, the main cause of osteomalacia is a lack of mineral 
supply for bone modeling and remodeling due to solar vitamin D and/or dietary 
calcium deficiency. Osteomalacia occurs when existing bone is replaced by 
unmineralized bone matrix (osteoid) during remodeling in children and adults, or 
when newly formed bone is not mineralized in time during modeling in children. 
Rickets occurs when hypomineralization affects the epiphyseal growth plate 
chondrocytes and adjacent bone metaphysis in growing children. Hence, 
osteomalacia co-exists with rickets in growing children. Several reports in the last 
decade highlight the resurgence of so-called “nutritional” rickets in the dark-skinned 
population living in high-income countries. However, very few studies have ever 
explored the hidden iceberg of nutritional osteomalacia in the population.  
Rickets presents with hypocalcaemic (seizures, tetany, cardiomyopathy), or 
hypophosphataemic complications (leg bowing, knock knees, rachitic rosary, muscle 
weakness) and is diagnosed on radiographs (cupping and fraying of metaphyses). In 
contrast, osteomalacia lacks distinctive, non-invasive diagnostic laboratory or 
imaging criteria and the clinical presentation is non-specific (general fatigue, malaise, 
muscle weakness and pain). Hence, osteomalacia remains largely undiagnosed, as 
a hidden disease in millions of dark-skinned people who are at greatest risk. 
Radiographs may demonstrate Looser’s zone fractures in those most severely 
affected, however to date, osteomalacia remains a histological diagnosis requiring a 
bone biopsy. Biochemical features of high serum alkaline phosphatase (ALP), high 
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parathyroid hormone (PTH) with or without low 25 hydroxyvitamin D (25OHD) 
concentrations are common to both rickets and osteomalacia.  
Here, we propose non-invasive diagnostic criteria for osteomalacia. We recommend 
a diagnosis of osteomalacia in the presence of high ALP, high PTH, low dietary 
calcium intake (<300 mg/day) and/or low serum 25OHD (<30 nmol/L). Presence of 
clinical symptoms (as above) or Looser’s zone fractures should be used to reaffirm 
the diagnosis.  
We call for further studies to explore the true prevalence of nutritional osteomalacia 
in various populations, specifically the Black and Asian ethnic groups, in order to 
identify the hidden disease burden and inform public health policies for vitamin 
D/calcium supplementation and food fortification.  
 
Keywords: Bone modeling, remodeling, biopsy, micronutrient, malnutrition, nutrition, 
bone turnover, rickets, osteomalacia, osteoporosis 
 
INTRODUCTION 
Osteomalacia results from defective mineralization of pre-formed osteoid laid down 
by osteoblasts, and occurs due to lack of mineral supply (calcium and phosphate), 
often secondary to a lack of calcitriol (active vitamin D) which is required for intestinal 
calcium absorption. Osteomalacia affects humans from conception to grave. In 
growing young children, osteomalacia leads to leg bowing and is accompanied by 
growth plate disarray with metaphyseal swellings referred to as rickets [1]. Although 
osteomalacia/rickets can occur due to inherited or acquired disorders causing 
hypophosphataemia, or defects in calcitriol synthesis/action or in the vitamin D 
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metabolism pathway [1], the leading causes worldwide, by far, remain solar (vitamin 
D deficiency) and/or dietary (calcium deficiency) [2]. Whilst sunshine and diet are 
completely different environmental factors, common terminology still summarises 
these factors as “nutritional” which can lead to confusion.  
’Nutritional’ osteomalacia and rickets due to dietary calcium deficiency are endemic 
in populations with low calcium intake typical for many low and middle income 
countries [3,4]. Osteomalacia and rickets are also re-emerging in high income 
countries at high latitude (i.e. most of Europe) where restricted sunlight is the main 
cause, predominantly affecting the Black, Asian and Minority Ethnic (BAME) groups 
with dark skin [5,6]. Melanin absorbs natural solar Ultraviolet B (UVB) radiation 
thereby reducing the amount of vitamin D synthesised.  Hence darker skin requires 
prolonged exposure to UVB compared to lighter skin to produce the same amount of 
vitamin D, and consequently the BAME population carries the highest risk of 
osteomalacia and rickets. However, subjects from any ethnic group will eventually 
develop vitamin D deficiency if they block sunlight (full body clothing, sunscreen, 
pollution, indoor living) or have no access to UVB containing sunlight (latitude), 
unless they take oral vitamin D supplements or fortified food. Hence many high 
income countries have National vitamin D supplementation and/or food fortification 
policies in place with major differences in implementation strategies and success at 
least in infants. Whilst the incidence of clinically evident nutritional rickets affecting 
children in high income countries is reported to be rising [7,8], the true prevalence of 
occult nutritional osteomalacia affecting both children and adults remain unidentified. 
Nutritional osteomalacia is the hidden body of the vitamin D deficiency iceberg which 
remains unexplored for several reasons including its insidious onset, non-specific 
clinical presentation and the lack of universally accepted diagnostic criteria. Those 
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affected largely go undiagnosed as evident by the extent of hidden biochemical 
osteomalacia in family members of infants presenting with hypocalcaemic dilated 
cardiomyopathy and rickets [6] and the incidental finding of widespread osteomalacia 
in adults at post-mortem [9]. Therefore, osteomalacia can be easily missed if the 
diagnosis is not considered and actively sought. Here, we highlight the pressing 
need for universal diagnostic criteria, studies exploring the true prevalence and 
public health prevention strategies for nutritional osteomalacia.  
What is osteomalacia? 
The term osteomalacia was originally used to describe softening of bones which 
resulted in crippling deformities [10]. The availability of in vivo tetracycline labelling 
for bone biopsy sampling enabled osteomalacia to be described as defective 
mineralization of osteoid. Osteomalacia occurs when resorbed bone is replaced by 
unmineralized bone matrix (osteoid) during the bone remodeling cycle (all humans), 
or wherever new bone is being laid down and not mineralized in time during bone 
modeling (growing children) [10].  
How does osteomalacia differ from rickets and osteoporosis? 
Rickets and osteomalacia have the same underlying pathological mechanism of 
defective mineralization due to lack of mineral supply. Whilst rickets affects the 
epiphyseal growth plate cartilage and adjacent bone metaphysis in growing children 
with open epiphyses, osteomalacia affects pre-formed osteoid in existing bone of 
both children and adults. Hence, osteomalacia always co-exists with rickets in 
children [1]. Although x-ray changes are only seen in the late stages of the disease 
process, rickets remains a radiological diagnosis. In contrast, whilst leg bowing is an 
obvious sign of osteomalacia, it cannot be diagnosed on radiographs and to date, 
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definitive diagnosis requires bone histomorphometry with tetracycline labelling 
(biopsy) [11,12]. 
Osteoporosis, on the other hand is not a bone mineralization defect, but a mass and 
structural defect leading to increased fragility. Osteoporosis occurs from reduced 
bone mass accrual in children or increased bone resorption in children and adults 
[13,14]. In adults, differentiating between osteoporosis and osteomalacia may be 
difficult since they may coexist when secondary hyperparathyroidism due to endemic 
vitamin D or calcium deficiency increases bone resorption [11,15]. A low bone 
mineral density (BMD) on a Dual Energy X-ray Absorptiometry (DXA) scan is noted 
in both conditions.  
How does nutritional osteomalacia present and who is at risk? 
The clinical presentation of osteomalacia is varied and depends on the age of 
presentation (Figure 1). Children, especially infants and adolescents, i.e. during 
phases of rapid growth, are most likely to be symptomatic due to high mineral 
demand in growing bones [16,17]. Infants are the most vulnerable group who 
present with life threatening hypocalcaemic complications such as seizures and 
tetany [18], heart failure secondary to dilated cardiomyopathy [19] and rarely cardiac 
death [6,19,20], as well as classical rickets signs. Bony deformities such as enlarged 
fontanelle, rachitic rosary, swollen joints are clinical signs of rickets and knock knees 
or bowed legs are clinical signs of the associated osteomalacia noted in infants or 
growing children. These signs do not develop in adults or adolescents after 
epiphyseal fusion, making the disease far less obvious in older age groups. Acute 
hypocalcaemic complications such as seizures are very rarely reported in adults [21]. 
However, it is not unusual for adults with osteomalacia to present to neurologists 
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with proximal muscle weakness [22,23] . Elderly and institutionalised individuals are 
likely to present with increased falls and fractures [24]. From a public health 
perspective, it is crucial to understand that clinical presentations of nutritional rickets 
or osteomalacia only represent the tip of the iceberg of widespread vitamin D and 
calcium deficiencies; the majority of the population suffer in silence as the hidden 
body of the deficiency iceberg remains unidentified (Figure 1). Post mortem studies 
have attempted to uncover the true burden of disease in children [20,25] using 
growth plate histology where nearly 70% of subjects showed histological evidence of 
rickets, although lacking in bone histomorphometric data [20,25]. An adult post-
mortem study (n=675) from Germany reported histomorphometric evidence of 
nutritional osteomalacia in nearly 25% of subjects [9], associated with low 25 
hydroxyvitamin D (25OHD) concentrations (<75 nmol/L),.   
We emphasise that investigation of acutely presenting infants with rickets and 
osteomalacia should also include maternal investigations as the vitamin D deficient 
state is naturally passed on from the mother [6,26]. Although rare, severe and 
prolonged deficiency states can cause obstructed labour in the mother [27] and also 
congenital rickets in the newborn [28-30]. Apart from the mother, investigations in 
anyone presenting with osteomalacia should certainly extend to all members of the 
family, as it is extremely likely that they all share the same risk factors such as skin 
colour (dark skin produces less vitamin D than light skin), dietary habits (diet low in 
dairy products or lack of supplements), cultural habits (covered clothing, sun 
avoidance) and geographic location (reduced sunlight and reduced skin synthesis of 
vitamin D at high latitude) [6]. At highest risk of nutritional rickets and osteomalacia is 
the dark skinned population residing in high latitude countries with restricted sunlight, 
lack of robust vitamin D supplementation programs and mandatory food fortification 
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policies [5,9,31-34]. In low and middle income countries with abundant sunshine, the 
populations at highest risk are those with dietary calcium deficiency and cultural 
whole body clothing [2-4].   
How is nutritional osteomalacia diagnosed?  
Osteomalacia is diagnosed on bone histomorphometry and is defined by a 
combination of osteoid thickness > 12.5 μm and a mineralization lag time of >100 
days [11]. Hypovitaminosis D osteopathy or pre-osteomalacia is characterized by an 
increase mainly in osteoid surface with a slight increase in osteoid thickness (usually 
just <12.5 μm) [11]. The availability of normative data has enabled the use of iliac 
bone histomorphometry also in growing children [35]. There is no significant natural 
variation with age (1.5 to 22.9 years) in osteoid thickness [n=58, median 6.1 μm 
(range 3.9–10.0), P=0.38] and mineralization lag time [n=48, median 15.1 days 
(range 8.7–29.1), P=0.75] [35]. 
The need for invasive bone biopsy and histomorphometry for a conclusive diagnosis 
has been perceived as discouraging and hence biopsies are rarely performed. 
However, it is not impossible to make a diagnosis without a bone biopsy and non-
invasive diagnostic criteria have been proposed (Box 1) [36,37], but are not 
universally adopted or suitable for all age groups.  
Box 1: Diagnostic criteria for adult osteomalacia proposed by a Japanese group [36] 
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Whilst these proposed criteria may help diagnose adult patients with severe and/or 
prolonged osteomalacia, those with mild to moderate disease and non-specific 
symptoms will be missed as features such as hypophosphataemia and low BMD or 
radiological changes only occur late in the disease process (Figure 2).   
We concur with others that it should be possible to diagnose nutritional osteomalacia 
non-invasively based on a combination of risk factors including a simple dietary 
history [21], clinical features, laboratory markers and some radiological features 
[23,36,37]. In patients with nutritional osteomalacia, the predisposing risk factors are 
obvious (geographic location, dark skin colour, whole body clothing) and a history of 
low calcium diet is imperative. In most cases, serum calcium and phosphate are 
initially normal in the early stages of the disease due to compensation by raised 
parathyroid hormone (PTH). A decreasing serum calcium level below its set-point is 
detected by the calcium sensing receptor in the parathyroid gland’s chief cells which 
stimulates PTH release. The raised PTH maintains calcium supply in the body by 
releasing calcium stored in the bones through osteoclastic bone resorption, 
increasing renal calcium absorption and stimulating 1-hydroxylase activity to 
maximize calcitriol synthesis [38]. Unless intervened at this stage with vitamin D 
(a) Hypophosphataemia or hyocalcaemia  
(b) High bone alkaline phosphatase level 
(c) Clinical symptoms: muscle weakness or bone pain  
(d) Low Bone Mineral Density: less than 80 % of young adult mean 
(e) Abnormal imaging findings: multiple uptake by bone scintigraphy or Looser’s 
zone by X-ray 
Definite osteomalacia: patients who have (a)–(e)  
Possible osteomalacia: patients who have (a), (b), and 2 of (c)–(e) 
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and/or calcium supplementation, long standing secondary hyperparathyroidism will 
eventually lead to failure of compensatory mechanisms causing renal phosphate 
wasting, ultimately manifesting as hypophosphataemia and/or hypocalcaemia. 
Hence, a raised PTH is a very good indicator of osteomalacia in risk groups with low 
25OHD concentrations and/or low dietary calcium. 25OHD concentrations below 25 
nmol/L are linked with osteomalacia on histomorphometry and almost always 
associated with raised serum alkaline phosphatase (ALP) and PTH concentrations 
[15]. Therefore, a raised ALP [37,38] in children or more specifically, bone specific 
alkaline phosphatase (BALP) in adults [36] are useful diagnostic serum markers in 
this setting. Here, we propose clinical criteria for the non-invasive diagnosis of 
osteomalacia that apply to all age groups, taking into account age- and sex-specific 
laboratory reference data (Box 2).  
Box 2: Proposed diagnostic criteria for osteomalacia in children and adults 
 
 
 
 
 
Looser’s zone fractures on radiographs, low BMD on DXA, increased tracer uptake 
on bone scintigraphy are not specific to osteomalacia. However, these radiological 
changes occur in the late stages of the disease where laboratory evidence of 
osteomalacia/rickets should already be overwhelming, thereby limiting their clinical 
utility. Other markers of bone resorption (i.e. carboxy-terminal telopeptide of type I 
1) High PTH 
2) High ALP 
3) Low dietary calcium (<300 mg/day) and/or low serum 25OHD (<30 nmol/L) 
4) Low urinary calcium 
Presence of the above features in the absence of renal/liver disease suggests 
a diagnosis of osteomalacia.  
Presence of clinical symptoms and radiological features (Looser’s zone 
fractures) help confirm the diagnosis in late stages (Figure 2).  
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collagen, amino-terminal telopeptide of type I collagen and deoxypyridinoline) or 
formation (i.e. amino-terminal propeptide of type I procollagen and osteocalcin) are 
of uncertain value in distinguishing between osteomalacia and osteoporosis [39].  
What are the practical difficulties in diagnosing osteomalacia in the 
community? 
Non-specific clinical presentation and lack of diagnostic markers:  
A high index of suspicion is necessary to diagnose osteomalacia in adults. Patients 
often present to general practitioners, rheumatologists or neurologists and 
nonspecific clinical features may lead to a delay in diagnosis and unnecessary 
investigations [11,21,23]. Specific knowledge of the main risk factors for 
osteomalacia such as ethnicity and dairy intake may be lacking. Physicians also tend 
to measure 25OHD only rather than the diagnostically far more important ALP and 
PTH. Unlike rickets which is a radiological diagnosis, osteomalacia is a histological 
diagnosis. Even in patients with osteomalacia, environmental causes are rarely 
assumed leading to a number of unnecessary investigations in the search for 
pathological causes. 
Differential diagnoses:  
1. Primary hyperparathyroidism: For the less experienced, increased PTH 
concentrations may also raise suspicion of primary hyperparathyroidism. 
However, in contrast to the low or normal serum calcium seen in secondary 
hyperparathyroidism, patients with primary hyperparathyroidism have high 
serum and urinary calcium. The fact that serum calcium is usually normal in 
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osteomalacia, and thus a very poor marker of the body’s calcium status, is not 
well known in the community. 
2. Osteoporosis: Long standing osteomalacia may be difficult to distinguish from 
osteoporosis as both conditions present with fractures and markedly reduced 
BMD on DXA scans [11]. Moreover, nutritional osteomalacia may co-exist with 
osteoporosis in old age, hence prevention and treatment of vitamin D or 
calcium deficiency in this age group is recommended [24].  
3. Malignancy: In the absence of prompt diagnosis and treatment, prolonged 
deficiency can mimic malignancy; clinically (weight loss) and radiologically 
(osteopenia on radiographs and widespread increased uptake on bone 
scintigraphy) [11,21]. Very rarely, FGF23 production by cancer cells may lead 
to tumour-induced osteomalacia (TIO), independent of vitamin D status or 
calcium intake.  
Why is it important to diagnose nutritional osteomalacia?  
Whilst several reports highlight the resurgence of nutritional rickets in developed 
countries [40-45], osteomalacia which goes hand in hand with rickets and likely 
affects a large proportion of the adult at-risk population is somewhat neglected.  
Disease burden: The national diet and nutritional survey in the United Kingdom 
reports low 25OHD concentrations (<25 nmol/L) in nearly 39% of the population in 
the 19-65 years age group [44] despite a profound underrepresentation of the dark 
skinned ethnic groups who are most at risk. However, the lack of additional 
metabolic bone markers (ALP, PTH) precludes the assessment of osteomalacia.   
Risk groups: The BAME group is at greatest risk of osteomalacia.  
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We have previously highlighted that two thirds of investigated family members of 
BAME infants with nutritional rickets showed biochemical signs of osteomalacia 
(raised ALP and PTH, and  25OHD < 30 nmol/L) [6].  
Immigrant /dark skinned mothers have lower 25OHD concentrations compared to 
white mothers [32,33,46]. Inspecting data from studies measuring PTH and/or ALP in 
addition to 25OHD concentrations shed further light on the prevalence of 
osteomalacia in the BAME population. A study of pregnant women in the north of 
England reported significantly higher PTH and lower 25OHD concentrations, in 
South Asian women compared to European women [32]. Although the study was not 
focussed on identifying osteomalacia, the extent of biochemical osteomalacia 
revealed by raised PTH was alarming. South Asian women when compared to 
European women had much lower median 25OHD (interquartile range in nmol/L) 
[n=783, 14.7 (9.7, 23.4) and n=596, 37.9 (26.7, 58.6) respectively, P .001] and 
higher median PTH (interquartile range in pmol/L) [n=780, 7.6 (5.0, 11.0) and n= 
594, 3.2 (2.3, 4.5) respectively, P<0.001] [32]. These findings were resonated in 
another study from the south of England reporting significant differences in PTH 
between the South Asian and Caucasian population (4.3 and 2.6 pmol/L respectively 
in autumn, P<0.001) [46].  
Morbidity and mortality: Osteomalacia is likely to contribute not just to morbidity 
but also mortality [6] in the BAME population.  Effects of nutritional osteomalacia due 
to vitamin D deficiency can be debilitating causing not only fatigue and malaise but 
also severe proximal myopathy [22] and muscle weakness [47,48]. Nutritional 
osteomalacia is entirely preventable [3] and easily reversible if identified early 
[11,49]. Undiagnosed osteomalacia however adversely affects quality of life, 
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moreover prolonged secondary hyperparathyroidism causes irreversible bone 
damage with cortical thinning [49] and increased lifetime fracture risk [50].  
What are the future research recommendations? 
Exploring the hidden body of the iceberg of nutritional osteomalacia [51] will have a 
significant benefit for designing public health policies such as vitamin D / calcium 
supplementation [31] and food fortification [52]. A good way of assessing the extent 
of the problem would be to incorporate bone metabolic markers such as ALP and 
PTH into national diet and nutritional surveys. The national surveys in high-income 
countries should include more people of BAME origin in order to be equally 
representative and avoid under-reporting the scale of the problem. Similar surveys in 
low and middle income settings are also important to study the effect of concomitant 
micronutrient deficiencies (such as iron and zinc) on vitamin D and/or calcium 
deficiency. Dynamic bone histomorphometry studies are needed to explore the 
relationship of clinical (dietary calcium intake) and laboratory markers (PTH, ALP, 
25OHD) with bone tissue mineralization in specific population groups (based on age, 
gender, ethnicity, pregnancy).   
Conclusions: Nutritional osteomalacia is widespread but the true prevalence 
remains unidentified. We propose non-invasive diagnostic criteria and call for studies 
exploring the true prevalence of hidden osteomalacia, in order to design better 
preventative public health policies.  
Conflict of interest: None declared 
Funding: None received 
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Figure 1: Spectrum of clinical presentation of nutritional rickets and osteomalacia from conception to old age. Clinically evident 
symptoms of rickets as well as osteomalacia only represent the tip of the iceberg. The iceberg’s hidden part (widespread 
solar vitamin D and dietary calcium deficiency) in the majority remains undiagnosed.  
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Figure 2: Stages of calcium deprivation, secondary to vitamin D and/or dietary calcium deficiency, that lead to osteomalacia in at 
risk individuals of all age groups. [Modified from Uday S, Högler W. Nutritional Rickets and Osteomalacia in the Twenty-first Century: Revised 
Concepts, Public Health, and Prevention Strategies. Curr Osteoporos Rep. 2017;15(4):293–302 in accordance with Creative Commons license 
(http://creativecommons.org/licenses/by/4.0/)].                
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